GNG2-MRAS interaction regulates SHOC2-dependent RAF activation and MAPK signaling
- 1Rowan University
Abstract
Dysregulation of the mitogen-activated protein kinase (MAPK) signaling pathway is a hallmark of many human cancers and RASopathies. The SHOC2-MRAS-PP1C; (SMP) holophosphatase complex is a crucial regulatory node of this pathway. It activates the MAPK pathway by dephosphorylating the inhibitory phosphoserine on RAF kinases and thereby relieving RAF autoinhibition. Although GNG2, the {gamma}-subunit of heterotrimeric G proteins, has recently emerged as a negative modulator of MAPK signaling, its molecular mechanism of action remains incompletely understood. Here, we identify GNG2 and its truncated variants as inhibitors of SMP complex assembly by directly targeting MRAS. Using NanoBiT live-cell bioluminescence, co-immunoprecipitation (Co-IP), biolayer interferometry (BLI), and molecular dynamics simulation studies, we demonstrate that full-length GNG2 (residues 1-71aa) and two helical fragments ({Delta}1, residues 1-29aa and {Delta}2, residues 30-71aa) bind MRAS, disrupt SMP complex formation, and therefore prevent RAF dephosphorylation. Expression of the truncated GNG2 variants significantly reduced phosphorylation of ERK in cells, consistent with inhibition of pathway activation. Furthermore, a short peptide synthesized from the GNG2 {Delta}2 sequence effectively disrupted SMP complex formation in both purified protein systems and live cells and potently attenuated MAPK signaling. Molecular dynamics simulation studies revealed that GNG2 variants engage with the Switch I/II regions of MRAS, sterically interfering with SHOC2-PP1C association. Together, these findings establish GNG2 as a direct regulator of SMP complex assembly and demonstrate that GNG2-derived peptides represent a promising strategy for disrupting SHOC2-MRAS interactions and suppressing MAPK signaling in RAS/RAF-driven pathologies.
Related
- UFSP2 constitutes a targetable vulnerability via deUFMylation-dependent activation of AKT oncogenic signaling
- Hepatic stellate cell FXR signaling regulates context-dependent functions in liver homeostasis and fibrosis.
- The Dystrophin Glycoprotein Complex Regulates the Epigenetic Activation of Muscle Stem Cell Commitment
- MRPL40 Regulates Cardiac Outflow Tract Septation by Modulating Neural Crest Cell Migration via CREB-MSX1 Signaling
- PACE4 Regulates Apoptosis in Human Prostate Cancer Cells via Endoplasmic Reticulum Stress and Mitochondrial Signaling Pathways [Retraction].
BibTeX
@misc{navale2026gng2mras,
title = {{GNG2-MRAS interaction regulates SHOC2-dependent RAF activation and MAPK signaling}},
author = {G. R. Navale and B. Towolawi and C. Christoff and S. Malasani and Z. Liu and Z. Wang},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.31.763144},
url = {https://www.biorxiv.org/content/10.64898/2026.10.31.763144v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - GNG2-MRAS interaction regulates SHOC2-dependent RAF activation and MAPK signaling
AU - G. R. Navale
AU - B. Towolawi
AU - C. Christoff
AU - S. Malasani
AU - Z. Liu
AU - Z. Wang
PY - 2026
DA - 2026/10/31
PB - bioRxiv
DO - 10.64898/2026.10.31.763144
UR - https://www.biorxiv.org/content/10.64898/2026.10.31.763144v1
AB - Dysregulation of the mitogen-activated protein kinase (MAPK) signaling pathway is a hallmark of many human cancers and RASopathies. The SHOC2-MRAS-PP1C; (SMP) holophosphatase complex is a crucial regulatory node of this pathway. It activates the MAPK pathway by dephosphorylating the inhibitory phosphoserine on RAF kinases and thereby relieving RAF autoinhibition. Although GNG2, the {gamma}-subunit of heterotrimeric G proteins, has recently emerged as a negative modulator of MAPK signaling, its molecular mechanism of action remains incompletely understood. Here, we identify GNG2 and its truncated variants as inhibitors of SMP complex assembly by directly targeting MRAS. Using NanoBiT live-cell bioluminescence, co-immunoprecipitation (Co-IP), biolayer interferometry (BLI), and molecular dynamics simulation studies, we demonstrate that full-length GNG2 (residues 1-71aa) and two helical fragments ({Delta}1, residues 1-29aa and {Delta}2, residues 30-71aa) bind MRAS, disrupt SMP complex formation, and therefore prevent RAF dephosphorylation. Expression of the truncated GNG2 variants significantly reduced phosphorylation of ERK in cells, consistent with inhibition of pathway activation. Furthermore, a short peptide synthesized from the GNG2 {Delta}2 sequence effectively disrupted SMP complex formation in both purified protein systems and live cells and potently attenuated MAPK signaling. Molecular dynamics simulation studies revealed that GNG2 variants engage with the Switch I/II regions of MRAS, sterically interfering with SHOC2-PP1C association. Together, these findings establish GNG2 as a direct regulator of SMP complex assembly and demonstrate that GNG2-derived peptides represent a promising strategy for disrupting SHOC2-MRAS interactions and suppressing MAPK signaling in RAS/RAF-driven pathologies.
ER -